[Federal Register: August 2, 2006 (Volume 71, Number 148)]
[Notices]
[Page 43813-43814]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr02au06-111]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on June 22, 2006, Clariant LSM
(Missouri) Inc., 2460 W. Bennett Street, or (P.O. Box 1246, zip 65801),
Springfield, Missouri 65807-1229, made application by renewal to the
Drug Enforcement Administration (DEA) to be registered as a bulk
manufacturer of the basic classes of
[[Page 43814]]
controlled substances listed in Schedules II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Methylphenidate (1724)..................... II
Phenylacetone (8501)....................... II
Methadone intermediate (9254).............. II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substance in
bulk for sale to its customer.
Any other such applicant and any person who is presently registered
with DEA to manufacture such a substance may file comments or
objections to the issuance of the proposed registration pursuant to 21
CFR 1301.33(a).
Any such written comments or objections being sent via regular mail
should be addressed, in quintuplicate, to the Deputy Assistant
Administrator, Office of Diversion Control, Drug Enforcement
Administration, Washington, DC. 20537, Attention: DEA Federal Register
Representative/ODL; or any being sent via express mail should be sent
to DEA Headquarters, Attention: DEA Federal Register Representative/
ODL, 2401 Jefferson-Davis Highway, Alexandria, Virginia 22301; and must
be filed no later than October 2, 2006.
Dated: July 26, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E6-12455 Filed 8-1-06; 8:45 am]
BILLING CODE 4410-09-P